Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 CAD | +0.54% |
|
+2.49% | -31.10% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.10% | 95.94M | |
+24.77% | 46.56B | |
+45.38% | 41.67B | |
+0.17% | 41.16B | |
+33.18% | 32.4B | |
+21.03% | 28.18B | |
-6.35% | 28.1B | |
+49.05% | 14.52B | |
+47.23% | 13.74B | |
+3.21% | 12.17B |
- Stock Market
- Equities
- EPRX Stock
- News Eupraxia Pharmaceuticals Inc.
- Eupraxia Pharmaceuticals Inc. Brief: Appointing Mark Kowalski, MD, PhD, as Company's Chief Medical Officer, effective May 18, 2023